Products for Research Use Only
RegisterLogin

IDRA 21

CAT: 0804-HY-101528-01Size: 10 mM - 1 mLDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-101528-01Size:10 mM - 1 mL
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
IDRA 21 is a positive and orally active modulator of the AMPA receptor. IDRA 21 facilitates excitatory neurotransmission via GluR1/2 receptors. IDRA 21 has the potential for the research of cognitive/memory disorders, including those associated with aging[1].
CAS Number
22503-72-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/idra-21.html
Purity
99.66
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CC(NC1=CC=C(Cl)C=C12)NS2(=O)=O
Molecular Formula
C8H9ClN2O2S
Molecular Weight
232.69
Precautions
H302, H315, H319, H335
References & Citations
[1]Buccafusco JJ, et al. The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys. Neuropharmacology. 2004 Jan;46 (1) :10-22. doi: 10.1016/j.neuropharm.2003.07.002.|[2]Yamada KA, et al. The diazoxide derivative IDRA 21 enhances ischemic hippocampal neuron injury. Ann Neurol. 1998 May;43 (5) :664-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
AMPA Receptor

Related Products

CatalogName
HY-14648S3Dexamethasone-4,6α,21,21-d4
HY-174975JY-21
HY-161144AKT-IN-21
HY-146408ALK-IN-21
HY-150545AChE-IN-21
HY-168188CYP51-IN-21
HY-149720-01GRL018-21
HY-142678EGFR-IN-21
HY-150081PRMT5-IN-21
HY-178098TEAD-IN-21

Alternative Products

CatalogName
530569IDRA-21
B6639-50IDRA 21

Popular Products